Archive: portfolio recommendation
By Early Investing on March 25, 2019
First Stage Investor Co-Founder Andy Gordon takes a deeper dive into why he likes Phoenix Pharma Labs so much and the "X" factor that put them over the top.
By Andy Gordon on February 11, 2019
This week, we’re checking in with two of our portfolio companies. HyperSciences is planning a big field test of its technology, while 20/20 GeneSystems is expanding its reach.